Terpinen-4-ol

DB12816InvestigationalSmall molecule

Terpinen-4-ol is under investigation in clinical trial NCT01647217 (Demodex Blepharitis Treatment Study).

Chemical structure of Terpinen-4-ol
Formula / weight
C10H18O · 154.253 g/mol (avg)

Resolves to

Compound
UNIIL65MV77ZG6CAS562-74-3ChEMBLCHEMBL507795ChEBI78884PubChem11230KEGGC17073
Clinical / RWD
RxNorm1314261
Structure
InChIKeyWRYLYDPHFGVWKC-UHFFFAOYSA-NSMILESCC(C)C1(O)CCC(C)=CC1
Targets
P22303ACHEP10415BCL2P98170XIAPP09923ALPI

What you can answer from here — as of April 02, 2025

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Terpinen-4-ol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In